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Abstract: Synthetic amphiphilic polymers have been established as potentially efficient 
agents to combat widespread deadly infections involving antibiotic resistant superbugs. 
Incorporation of poly(ethylene glycol) (PEG) side chains into amphiphilic copolymers can 
reduce their hemolytic activity while maintaining high antibacterial activity. Our study found 
that the incorporation of PEG has substantially different effects on the hemolytic and 
antibacterial activities of copolymers depending on structural variations in the positions of 
cationic centers relative to hydrophobic groups. The PEG side chains dramatically reduced 
the hemolytic activities in copolymers with hydrophobic hexyl and cationic groups on the 
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same repeating unit. However, in case of terpolymers with cationic and lipophilic groups 
placed on separate repeating units, the presence of PEG has significantly lower effect on 
hemolytic activities of these copolymers. PEGylated terpolymers displayed substantially 
lower activity against Staphylococcus aureus (S. aureus) than Escherichia coli (E. coli) 
suggesting the deterring effect of S. aureus’ peptidoglycan cell wall against the penetration 
of PEGylated polymers. Time-kill studies confirmed the bactericidal activity of these 
copolymers and a 5 log reduction in E. coli colony forming units was observed within 2 h of 
polymer treatment. 
Keywords: antimicrobial polymers; amphiphilic polymers; polyacrylates; drug-resistant 
bacteria; PEGylated; bactericidal agents 
 
1. Introduction 
The global health threat from infections involving antibiotic resistant bacteria (superbugs) have created 
a pressing need to develop new antibacterial agents [1,2]. Antimicrobial resistance to antibiotics causes 
thousands of deaths and adds billions of dollars to health care budget in the Unites States alone [3–5].  
It has been recently estimated that antimicrobial resistance will result in 10 million annual deaths by 
2050 [6]. The problem of antibiotic resistance is further compounded by sharp decline in number of new 
antibiotics introduced in market in recent years due to high costs involved in their development facing 
the rapid development of microbial resistance against antibiotics [1]. Synthetic cationic amphiphilic 
polymers mimicking the principle features of natural antimicrobial peptides (AMPs) have emerged as 
promising candidates to fight against superbugs [7,8]. AMPs and their synthetic mimics are known to 
disrupt the negatively charged bacterial cell surface through electrostatic and lipophilic interactions [9–11]. 
This mechanism of bacterial cell surface rupture through non-specific interactions leads to highly 
hindered or improbable development of bacterial resistance, which is in contrast to the rapid resistance 
development against conventional antibiotics with target specific mode of action [9]. The lack of bacterial 
resistance development towards synthetic amphiphilic polymers have been reported [12], whereas the 
development of significant bacterial resistance against conventional antibiotic is well documented. 
For widespread therapeutic applications, synthetic polymers with high antibacterial activity and 
concomitant low hemolytic activity and toxicity towards mammalian cells are desired. Research efforts 
have been focussed to ascertain the effects of various macromolecular structural parameters on the 
hemolytic and antibacterial activities of synthetic amphiphilic polymers. Structural parameters that have 
been reported to significantly impact the hemolytic and antibacterial activities include the block versus 
random copolymer architecture [13], amphiphilic balance [14], type of cationic charge [15], facially 
versus segregated amphiphilicity [16], charge density [17], backbone spacer distance [18], and terminal 
groups [19]. We have reported that the control of spatial charge distribution in polyacrylates with various 
compositions of 6-carbon and 2-carbon spacer arm (distance between polymer backbone to cationic 
center) repeat units can lead to polymers with high antibacterial and concomitant low hemolytic activity [20]. 
In another approach, we investigated the hemolytic and antibacterial activities of polyacrylates (6-carbon 
spacer arm counits) as a function of polymer amphiphilicity through control of non-ionic hydrophilic 
Int. J. Mol. Sci. 2015, 16 23869 
 
 
poly(ethylene glycol) (PEG) content [21]. The cationic homopolymer with 6-carbon spacer arms  
PM6-100%, i.e., poly(6-aminohexylacrylate), is highly hemolytic and antibacterial [20,22]. We found 
that the incorporation of just 33 mol % of poly(ethylene glycol) methyl ether methacrylate comonomer 
(PEGMA-300) units in this 6-carbon spacer arm polymer led to >1300 times reduction in hemolytic 
activity while maintaining high antibacterial activity, leading to >100 times selectivity against 
Escherichia coli (E. coli) over red blood cells (RBCs) [21]. In these copolymers with long hexyl spacer 
arms, the cationic charge and hydrophilic moieties are present on the same repeating unit. It would be  
of importance to understand the effect of polymer structure, in terms of relative placement of cationic 
and hydrophobic groups, on the impact of PEGylation on hemolytic and antibacterial activities of 
amphiphilic polymers. 
The aim of present investigation is to explore the effect of PEG group incorporation in copolymers 
having cationic groups and hydrophobic alkyl chains on separate repeating units. These results can be 
directly compared with our recently synthesized PEGylated 6-carbon spacer arm polymers with cationic 
and alkyl groups on the same repeating units [21]. Our study revealed that the incorporation of PEG 
counits has substantially different effects on the antibacterial and hemolytic activities of polymers  
with topographical differences in the placement of cationic groups relative to hydrophobic groups.  
The copolymers displayed high bactericidal activity with 5 log reduction of E. coli colony forming units 
within 2 h of treatment with a copolymer. 
2. Results and Discussion 
2.1. Synthesis of Copolymers 
The copolymers were synthesized through free radical copolymerization of 2-((tert-butoxycarbonyl) 
amino)ethyl acrylate and PEGMA-300 with butyl or hexyl acrylate using 2,2'-azobis(2-
methylpropionitrile) (AIBN) as a free radical initiator and methyl 3-mercaptopropionate (MMP) as a 
chain transfer agent (Figure 1) [20,21]. Two series of copolymers, one with butyl side groups and the 
other with hexyl side groups were synthesized to explore the effect of copolymer hydrophobicity on the 
antibacterial and hemolytic activities. The ratio of monomers to AIBN and MMP was kept constant to 
obtain similar molecular weights for all copolymers. Molecular weights of copolymers were estimated 
against linear polystyrene standards using gel permeation chromatography and found to be similar for 
all copolymers (Mn ~ 4000 g/mol). The feed mole ratio of 2-((tert-butoxycarbonyl)amino)ethyl acrylate 
to hexyl or butyl acrylate was kept constant at 60:40, whereas the feed mole ratio of PEGMA-300 (PEG 
side groups degree of polymerization (DP)~5) was varied from 0 mol % to 50 mol % in increments of 
10 mol %. Copolymers with 75 mol % of PEGMA were also synthesized. The DP of PEG side group 
was kept at 5 ethylene glycol units as our earlier study has found that PEGMA-300 led to polymers with 
higher selectivities against bacteria over RBCs, as compared with copolymers incorporating longer  
PEG side groups (DP~19, PEGMA-950) [21]. The actual feed ratios of polymers were confirmed  
using 1H-NMR spectroscopy and found to be in close agreement with the feed mole ratios (supporting 
information). For the removal of N-Boc protecting groups, copolymers were treated with excess 
trifluoroacetic acid. The nomenclature of PB-PEG X% is used to identify the cationic copolymer  
with butyl acrylate comonomer units and X mol % (in feed) of PEGMA-300 comonomer units.  
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Similarly, PH-PEGX % represents the copolymer with hexyl acrylate and X mol % (in feed) of  
PEGMA-300 counits. 
 
Figure 1. (A) Effect of relative topographical positions of cationic and lipophilic groups on 
the biological activities of PEGylated copolymers (The questions marks in part A signifies 
that the antibacterial and hemolytic activities of the terpolymer is unknown and the aim of 
this study was to explore the activities of this terpolymer); and (B) Synthesis of cationic 
amphiphilic copolymers through free radical polymerization. 
2.2. Antibacterial Activity of Copolymers 
The antibacterial activities of copolymers were determined against both gram negative E. coli 
(ampicillin resistant) and the gram positive Staphylococcus aureus (S. aureus) bacteria in terms of 
minimum inhibitory concentrations (MIC). MIC is defined as the lowest polymer concentration required 
to completely inhibit bacterial growth after an incubation period of 18 h. As apparent from Figure 2  
and Table 1, PH-PEG-0% displayed high antibacterial activity towards both E. coli and S. aureus.  
Kuroda et al. have reported high antibacterial activity in polymethacrylate copolymers having high mol 
% of hydrophobic butyl side groups [23]. As compared with PH-PEG-0%, PH-PEG-10% showed higher 
activity against E. coli (MIC: 16 µg/mL). Addition of small mol % of non-ionic hydrophilic PEG content 
has been previously reported to enhance the antibacterial activity of N-hexylated poly(vinyl pyridines) 
due to increased wettability in aqueous medium and hence better interactions with the bacterial cell 
surface [24]. In PH-PEG-0%, high hydrophobicity due to long hexyl side groups can lead to hydrophobic 
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associations of polymer chains in aqueous solution leading to lower number of polymer chains available 
for interactions with the bacterial cells [23]. Further increase in the mol % of PEGMA-300 repeat units 
till 50 mol % did not substantially deteriorate the antibacterial activity of these copolymers, but higher 
than 50 mol % (75 mol %) content led to complete loss of activity against E. coli (MIC > 1000 µg/mL). 
Similar to the effect of PEG on PH copolymer series with hexyl side groups, the addition of PEG side 
groups did not drastically reduce the antibacterial activities of PB series copolymer until 50 mol % of 
PEGMA-300 content, and copolymer with 75 mol % was not active against E. coli. These observations 
are similar to the effects of PEG content on the antibacterial activities of PEGylated PM6 copolymers 
(Table 1) with cationic charge and hydrophobic hexyl spacer arms on the same repeat units [21]. 
 
Figure 2. Antibacterial (MIC) and hemolytic activities (HC50) of (A) PB-PEG-X% series, 
terpolymers of butyl acrylate (shown in red in structure), 2-((tert-butoxycarbonyl)amino)ethyl 
acrylate, and PEGMA-300; (B) PH-PEG-X% series, terpolymers of hexyl acrylate (shown in 
red in structure), 2-((tert-butoxycarbonyl)amino)ethyl acrylate, and PEGMA-300. Error bars 
represent standard deviation. 
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Table 1. Characterization and biological activities of amphiphilic polyacrylates. 
Copolymer Alkyl Side Group 
Mol % PEGMA-300 
(Actual) 
Mn [g/mol] 
kDa 
MIC E. coli 
[µg/mL] 
MIC S. aureus 
[µg/mL] 
HC50 RBC 
[µg/mL] 
Selectivity HC50/MIC 
E. coli S. aureus 
PB-PEG-0% Butyl 0% 4.0 16 62 <12 <1 <1 
PB-PEG-10% Butyl 17% 4.2 52 83 <12 <1 <1 
PB-PEG-20% Butyl 23% 3.8 42 125 24 <1 <1 
PB-PEG-30% Butyl 33% 4.1 31 250 140 4.5 <1 
PB-PEG-40% Butyl 44% 4.2 62 604 317 5 <1 
PB-PEG-50% Butyl 53% 4.5 167 1143 1000 6 <1 
PB-PEG-75% Butyl 72% 4.6 2000 2000 2000 1 1 
PH-PEG-0% Hexyl 0% 3.4 62 42 <12 <1 <1 
PH-PEG-10% Hexyl 11% 3.6 16 62 <12 <1 <1 
PH-PEG-20% Hexyl 21% 3.8 21 83 24 1 <1 
PH-PEG-30% Hexyl 27% 3.9 21 384 24 1 <1 
PH-PEG-40% Hexyl 35% 4.6 42 384 62 1.5 <1 
PH-PEG-50% Hexyl 46% 4.6 83 1143 125 1.5 <1 
PH-PEG-75% Hexyl 72% 6.4 1190 2000 1500 1.3 <1 
PM6-100 * Hexyl 0% 5.8 6.5 16 <1.9 <1 <1 
PM6-90-PEG300 * Hexyl 10% 5.1 7.8 31 83 11 2.6 
PM6-70-PEG300 * Hexyl 33% 5.2 16 62 >1809 >113 >29 
PM6-50-PEG300 * Hexyl 50% 5.1 104 250 >2000 >19 >8 
PM6-30-PEG300 * Hexyl 71% 5.9 >1809 >2000 >200 >1 1 
* Yang et al. [21]. 
 
Int. J. Mol. Sci. 2015, 16 23873 
 
 
As shown in Figure 2 and Table 1, these PEGylated terpolymers displayed substantially lower activity 
against gram positive S. aureus, as compared with gram negative E. coli. Furthermore, increasing the 
PEGMA-300 content from 0 mol % to 40 mol % led to dramatic reduction in activity against S. aureus. 
Similarly, PEGylated PM6 copolymers (Table 1) previously demonstrated lower activity against  
S. aureus than E. coli [21]. These observations are in contrary to other studies that reported higher 
activities of synthetic amphiphilic polymers (without PEG) against S. aureus than E. coli [25–27].  
The double membrane structure of E. coli cell surface can be considered more difficult to penetrate  
than the single membrane cell surface of S. aureus [25]. However, dramatically lower activity of these 
PEGylated copolymers against S. aureus than E. coli suggests the probable hydrogen bonding 
associations of long PEG side groups with the thick (15–80 nm) peptidoglycan cell wall of S. aureus, 
thus hindering the permeabilization of PEGylated polymers through the cell surface of S. aureus. 
2.3. Hemolytic Activity of Copolymers 
The toxicity of these copolymers against mammalian cells was ascertained in terms of hemolytic 
activity against freshly drawn mice RBCs. Hemolytic concentration-50% (HC50) is defined as the lowest 
polymer concentration required to lyse 50% of RBCs within an incubation period of 1 h. The hemolytic 
activity of amphiphilic polymers has been mainly attributed to the permeabilization of polymers into 
the hydrophobic core of RBC’s lipid bilayer through lipophilic interactions [28]. The outer leaflet 
of RBCs’ cell membrane lacks net negative charge in contrary to the negatively charged cell surface of 
bacteria [28]. The incorporation of hydrophilic PEG side groups is expected to reduce the hemolytic 
activities of synthetic amphiphilic polymers. Similar to the protective action of blood plasma, PEG is 
believed to hinder the damage to RBCs from the foreign body contact [29]. PEG can weakly adsorb on 
the surface of RBCs thus further enhancing its protective action [30]. Moreover, the addition of 
hydrophilic PEG groups can reduce the overall hydrophobicity of polymers and then their insertion 
through the hydrophobic core of RBC’s lipid bilayer. 
However, majority of these PEGylated terpolymers displayed high hemolytic activity (Figure 2 and 
Table 1). As shown in Table 1, both PM6-100% (HC50 < 2 µg/mL) and PB-PEG-0% (HC50 < 12 µg/mL) 
displayed high hemolytic activities. However, incorporation of just 33 mol % of PEGMA-300 led to 
dramatic reduction in hemolytic activity (HC50 > 1809 µg/mL) in PM6-70-PEG300 leading to >113 
times selectivity (HC50/MIC) against E. coli over RBCs. In comparison, PB copolymers showed 
substantially higher hemolytic activity till 50 mol % of PEG side groups. Thus, the topographical 
placement of cationic centers relative to hydrophobic alkyl moieties significantly affects the ability of 
PEG groups to reduce the hemolytic activity of these amphiphilic copolymers. In PM6-70-PEG300, with 
hexyl groups (as spacer arms) present on the same repeating unit with cationic groups, the addition of 
PEG dramatically reduced the hemolytic activities of this copolymer. On the other hand, PB-PEG-40% 
containing butyl and cationic groups (attached to 2-carbon spacer arm) on separate repeat units displayed 
high hemolytic activity despite the high PEG mol % content. Tew and co-workers have previously 
reported that “facially amphiphilic” polynorbornenes demonstrated higher selectivities against bacteria 
over RBCs, as compared with “segregated” polynorbornenes with cationic and alkyl groups on separate 
repeat units [16]. Similarly, Sen and co-workers have shown higher selectivity of poly(vinyl pyridines) 
against bacteria over RBCs as compared with separate center copolymers [31]. Our investigations have 
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revealed that the relative positions of cationic and hydrophobic groups along the polymer backbone can 
have dramatic effect on the ability of PEG groups to protect erythrocytes from the lytic ability of 
synthetic amphiphilic polyacrylates and these results can have implications in the design of PEGylated 
polymers for biomedical applications. 
PH series copolymers in general displayed higher hemolytic activity than the PB series with shorter 
butyl side groups. This result is expected due to higher hydrophobicity of copolymers with longer hexyl 
side groups leading to higher ability of these copolymers to rupture the cell membrane of RBCs through 
lipophilic interactions. 
2.4. Time Dependent Killing Efficiency of Copolymers 
Time dependent killing efficiencies of PB-PEG-30% and PH-PEG-30% were obtained against E. coli 
and S. aureus (Figure 3). Both polymers displayed high bactericidal efficiency against E. coli and a 5 log 
reduction in E. coli colony forming units was obtained within 2 h of incubation with 1 × MIC 
concentration of PH-PEG-30%. These results confirmed the killing activity of these polymers, as 
opposed to only bacteriostatic activity and indicate that the minimum bactericidal concentration of these 
polymers against E. coli is equal to their minimum inhibitory concentrations. 
 
 
Figure 3. E. coli colony forming units (CFUs) after treatment with PB-PEG-30% at (A) 0 h 
and (B) at 6 h time interval. Time dependent killing efficiency of PB-PEG-30% and  
PH-PEG-30% copolymers at 1 × MIC concentration against (C) E. coli and (D) S. aureus.  
PB-PEG-30% and PH-PEG-30% terpolymers incorporate approximately 30 mol % of 
PEGMA-300. Error bars represent standard deviation. 
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As discussed above, these PEGylated copolymers demonstrated significantly lower activity against 
S. aureus than E. coli. As apparent from Figure 3, a substantial number of S. aureus colonies survived 
after treatment with 1 × MIC concentration of PB-PEG-30% even after 6 h of treatment, whereas more 
than 98% E. coli were killed within 2 h of treatment with PB-PEG-30%. In contrast to PB-PEG-30%,  
PH-PEG-30% displayed 100% killing against S. aureus at 1 × MIC concentration. Longer hexyl groups 
in PH-PEG-30% can lead to higher cell membrane permeability of polymer chains due to increased 
hydrophobic interactions with bacterial cell surface. Longer hydrophobic hexyl side groups can lead to 
more collapsed conformation of polymer chains in the aqueous medium leading to reduced association 
of PEG groups with the S. aureus cell wall. 
3. Experimental Section 
3.1. Materials 
Ethanolamine, hexyl acrylate, butyl acrylate, 2,2ʹ-azobis(2-methylpropionitrile) (AIBN), methyl  
3-mercaptopropionate (MMP), acetonitrile (anhydrous), N,N-diisopropylethylamine, and tetrahydrofuran 
(THF) were purchased from Sigma-Aldrich (Milwaukee, WI, USA) and used without further 
purification. Poly(ethylene glycol) methyl ether methacrylate (PEGMA-300, Mn ~300 g/mol) and 
acryloyl chloride were purchased from Sigma-Aldrich. Acryloyl chloride was distilled prior to use and 
poly(ethylene glycol) methyl ether methacrylate was purified (inhibitor removal) by silica gel column 
chromatography using dichloromethane as eluent. Trifluoroacetic acid (TFA), di-tert-butyl dicarbonate 
(t-Boc), hexane, and diethyl ether were purchased from Alfa Aesar (Ward Hill, MA, USA). 
Dichloromethane and ethyl acetate were purchased from BDH/VWR (Bridgeport, CT, USA). All other 
chemicals or reagents were used as obtained without further purification. 
3.2. Instrumentation 
1H-NMR spectra of polymers were obtained on a Varian NMR spectrometer (600 MHz, Varian: Palo 
Alto, CA, USA) using D2O as solvent. The molecular weights (MW, Mn, and polydispersities) of 
precursor polymers (N-Boc protected) were estimated on an EcoSec HLC-83220 gel permeation 
chromatography instrument (RI detector, TSKgel SuperHZ-N (3 µm 4.6 mm ID) and TSKgel Super  
HZ-M (3 µm 4.6 mm ID) columns) by Tosoh Bioscience (Tosoh Bioscience LLC: South San Francisco, 
CA, USA). Linear polystyrenes were used as standards and THF was used as an eluent at a flow rate of 
0.35 mL/min. An Agilent 8453 spectrophotometer (Agilent Technologies, Inc.: Santa Clara, CA, USA) 
was used to measure bacterial cell growth (using 1 cm path length plastic cuvette) in E. coli and S. aureus 
cell cultures. SpectraMax 340 PC microplate reader from Molecular Devices (Molecular Devices: 
Sunnyvale, CA, USA) was used to obtain OD595 (optical density at wavelength of 595 nm) for 
antibacterial test and OD414 for hemolysis test. 
3.3. N-Boc Protection of Ethanolamine 
Eight milliliters (132 mmol) of ethanolamine was added into a 250 mL round bottom flask containing 
132 mL deionized water. Thirty milliliters (130 mmol) of di-tert-butyl dicarbonate (t-Boc) was then 
dropwise added [20]. The reaction mixture was left under stirring at room temperature for 3 h.  
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N-Boc protected ethanolamine was extracted using ethylacetate (3 × 125 mL) and the organic phase was 
separated and dried with sodium sulfate. Excess solvent was removed using a rotary evaporator under 
reduced pressure. The final product was obtained as white powder in 92% yield. 1H-NMR (600 MHz, 
CDCl3): δ 1.4 (s, 9H), 3.3 (m, 2H), 3.7 (m, 2H), 5.3 (s, 1H). 
3.4. Synthesis of 2-((Tert-butoxycarbonyl)amino)ethyl Acrylate Monomer 
Fourteen grams (87 mmol) of N-Boc ethanolamine was added in a 500 mL two neck round bottom 
flask already charged with 23 mL (130 mmol) N,N-diisopropylethylamine and 130 mL anhydrous 
dichloromethane [20]. The reaction mixture was closed and purged with nitrogen. A volume of 7.32 mL 
of acryloyl chloride was added dropwise into the reaction mixture (while stirring) under nitrogen 
atmosphere at 0 °C. The reaction mixture was allowed to warm to room temperature and left under 
stirring for 18 h. The reaction mixture was then washed with deionized water (3 × 125 mL), 10% citric 
acid (3 × 125 mL), 10% potassium carbonate solution (3 × 125 mL), and saturated sodium bicarbonate 
solution (3 × 125 mL). The organic phase was separated and dried with sodium sulfate. Excess solvent 
was removed under reduced pressure using the rotary evaporator. The resultant liquid was purified by 
column chromatography using ethyl acetate/hexane (1:1) mixture as eluent. 65% yield. 1H-NMR  
(600 MHz, CDCl3): 1.40 (s, 9H), 3.47 (s, 2H), 4.22 (s, 2H), 5.83 (d, 1H), 6.10 (q, 1H), 6.39 (d, 1H). 
3.5. Synthesis of Copolymers 
A representative synthetic procedure is as follows [20,21]. 2-((tert-butoxycarbonyl)amino)ethyl 
acrylate (0.387 g, 1.8 mmol), 0.187 g (1.2 mmol) hexyl acrylate, and 0.900 g (3 mmol) PEGMA-300 
were added into a 100 mL three-neck round bottom flask which was already charged with 9.85 mg  
(0.06 mmol) AIBN, 33.3 µL MMP, and 6 mL anhydrous acetonitrile. The flask was sealed and degassed 
with nitrogen (using stainless steel needle) for 20 min. The reaction mixture was then stirred for 18 h at 
65 °C. Afterwards, acetonitrile in the solution was removed under reduced pressure using the rotary 
evaporator (Buchi Analytical Inc.: New Castle, PA, USA). The polymer was dissolved in THF and 
precipitated in hexane three times. In order to remove N-Boc protecting groups, the polymer was 
dissolved in excess TFA and the solution was stirred at room temperature for 3 h. Afterwards the TFA 
was removed under reduced pressure using the rotary evaporator and the polymer was dissolved in 
methanol and precipitated in diethyl ether multiple times. Resultant polymer was kept under vacuum for 
3 days and lyophilized. Yield 0.82 g. 
3.6. Antibacterial Activity Test 
Antibacterial activities of cationic amphiphilic copolymers were determined against E. coli (TOP 10, 
ampicillin resistant) and S. aureus ATCC 25923 using a microdilution assay as described in the  
literature [23]. Stock solutions (20 mg/mL) of polymers were prepared by dissolving each polymer in 
dimethyl sulfoxide. To obtain different concentrations, serial dilutions and some intermediate dilutions 
were prepared by further adding deionized water. Control solutions (without polymer) were similarly 
prepared. E. coli bacteria were incubated overnight at 37 °C, under shaking, in culture tubes containing 
Luria Bertani (LB) broth and ampicillin. Bacterial growth was measured with an Agilent 8453 
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spectrophotometer (Agilent Technologies, Inc.: Santa Clara, CA, USA) using a disposable plastic 
cuvette with a path length of 1 cm. The device measures turbidity at λ = 595 nm (optical density, OD595). 
The bacterial culture was diluted with fresh LB to achieve the OD600 = 0.1 of cell suspension and this 
suspension was incubated at 37 °C for approximately 90 min. The OD595 value was increased to 0.5, 
indicating the log-phase of exponential growth. The culture was then diluted with fresh LB broth to 
obtain a final OD595 value of 0.001. Polymers or control solutions were added to the 96 well cell culture 
plates followed by the addition of final E. coli cell suspension and the plates were incubated at 37 °C for 
18 h to promote bacterial growth. Bacterial growth was measured on a SpectraMax 340 PC microplate 
reader, using turbidity at λ = 595 nm (OD595). Antibacterial activity of polymers was similarly determined 
against S. aureus, except Mueller-Hinton (MH) broth was used in place of LB broth and longer log phase 
time intervals were required. Minimum inhibitory concentration (MIC) is defined as the lowest polymer 
concentration required to completely inhibit the bacterial growth after an incubation period of 18 h. MIC 
values reported here are the averages of three independent experiments on separate days. 
3.7. Hemolytic Activity Test 
Hemolytic activity of copolymers was tested against mice red blood cells (RBCs) [23]. The RBCs 
were obtained from centrifuging the freshly drawn blood at 3000 rpm for 15 min. Plasma and white 
blood cells were removed as supernatant. RBCs were washed with TBS (Tris-buffered saline; 10 mM 
Tris, 150 mM NaCl, at pH = 7) solution. The RBCs were 40-fold diluted with TBS solution to prepare 
a final 0.25% RBC stock solution. The stock solution (120 µL), polymer solution (15 µL) or control 
solution, and TBS solution (15 µL) were added to 600 µL micro centrifuge tubes and incubated at 37 °C 
for 1 h. The tubes were then centrifuged for 5 min at 4000 rpm. The resultant supernatant (30 µL,  
in triplicate) and 70 µL TBS were added in each well of the 96 well tissue culture plates. Hemoglobin 
concentration was measured as OD414, and the percent hemolysis corresponding to each polymer 
concentration was calculated using the following formula: 
%	ܪ݁݉݋݈ݕݏ݅ݏ = 	 ൬ܱܦସଵସܲ݋݈ݕ݉݁ݎ − ܱܦସଵସ݊݁݃ܽݐ݅ݒ݁ ܥ݋݊ݐݎ݋݈ܱܦସଵସܶݎ݅ݐ݋݊ − ܱܦସଵସ݊݁݃ܽݐ݅ݒ݁ ܥ݋݊ݐݎ݋݈ ൰ × 100 (1)
Hemolytic activity-50% (HC50) is defined as the lowest polymer concentration required to cause 50% 
lyses in RBCs within an incubation period of 1 h. The HC50 values reported here are the averages of  
two independent experiments performed on separate days. 
3.8. Time Dependent Killing Efficiency Test 
The time dependent killing efficiencies of polymers were obtained as per reported procedure [21]. E. coli 
and S. aureus bacterial cell cultures were obtained in log phase growth as described above in the 
antibacterial test section. A final stock solution with OD595 = 0.001 (~105 CFU/mL) was obtained by 
diluting the log phase cell suspension with fresh nutrient broth (LB broth for E. coli and MH broth for  
S. aureus). This final stock cell suspension was treated with polymer solutions (1 × MIC final concentration) 
or deionized water (without polymer) as control. At regular time intervals (1, 2, 4, and 6 h) the bacterial 
cell suspension samples were taken out. After serial dilutions (in 10 folds), 20 µL of the final dilution was 
streaked on agar plates and left for incubation for 24 h at 37 °C. The colony forming units were counted 
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using the image J image processing and analysis software (National Institute of Health: Bethesda, MD, 
USA). Results shown here are the averages of 2 independent experiments performed on separate days. 
4. Conclusions 
In conclusion, PEGylated cationic amphiphilic acrylate copolymers with high antibacterial activity 
against E. coli and S. aureus were synthesized. Time-kill studies revealed a 5 log reduction in E. coli 
CFUs/mL within 2 h of polymer treatment. As compared with PB-PEG-30%, PH-PEG-30% with two 
carbon longer alkyl side group displayed higher bactericidal activity against S. aureus with 100% killing 
of S. aureus cells within 2 h. The PEGylated copolymers reported here demonstrated substantially lower 
activity against S. aureus than E. coli. The hydrogen bonding association of hydrophilic PEG groups 
with peptidoglycans in the thick cell wall of S. aureus can be a contributing factor to this observation. 
The effect of non-ionic hydrophilic modifications on the antibacterial and hemolytic activities of 
amphiphilic polyacrylates was investigated. A significantly different impact of PEGylation on the 
hemolytic activities of polymers with variation in relative positions of cationic and hydrophobic centers 
was observed. As reported earlier, in copolymers with cationic centers and hydrophobic units (hexyl 
spacer arms) on the same repeat units, the incorporation of PEGMA-300 counits dramatically reduced 
the hemolytic activity without affecting antibacterial activity, as compared with the homopolymer  
PM6-100% lacking PEG groups. Similar to the high hemolytic activity of PM6-100%, PB-PEG-0% 
without PEG content and with cationic and alkyl groups present on separate repeat units showed high 
hemolytic and antibacterial activities. However, the incorporation of PEGMA-300 did not substantially 
mitigate the hemolytic activity of these copolymers even at a high mol % (40%) content of PEGMA-300. 
These results indicate that the PEG’s protective effect on RBCs is greatly influenced by the topographical 
placements of cationic centers and hydrophobic groups along the polymer chain. A PEGylated polymer 
architecture with long hydrophobic spacer arms for pendent cationic groups can result in high 
antibacterial and simultaneous low toxicity towards mammalian cells. 
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